ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

A CROSS-SECTIONAL RESEARCH TO ASSESS THE VARIOUS MANAGEMENT OPTIONS AND DISEASE-CAUSING AGENTS AMONG THE PATIENTS OF PPH (PRIMARY POSTPARTUM HEMORRHAGE)

AUTHORS:

Dr Alishba Tariq, Dr Aisha Siddiqi, Dr Hira Tariq

ABSTRACT:

Objective: This particular research aims to indicate various disease management options and the causes of the disease among primary postpartum haemorrhage patients. Patients and Methods: We completed this cross-sectional research at Gynecology and Obstetrics Department of Sir Ganga Ram Hospital, Lahore commencing from February 2017 to August 2017 on a total of 120 PPH Primary Postpartum Hemorrhage patients. We also determined the available management options and causes of the disease among the selected patients. Results: Selected patients were in the age group where the minimum and maximum age was respectively twenty and forty years with a mean age of (32.43 ± 6.23) years. Various age group were (20 – 25), (26 – 30), (31 – 35) and (36 – 40) years respectively including 36, 26, 19 and 39 patients with respective proportions of 30%, 21.67%, 15.83% and 32.5%. About parity, 36 patients were primiparous (30%), 81 patients were multiparous (67.5%) and 3 patients were grand multiparous (2.5%). The most repeated cause of PPH was uterine tony which was common among 78 patients (65%). We carried out hysterectomy among 50 patients (41.6%). Conclusion: Majority of the patients were in the age bracket of (36 – 40) years and they were also multiparous. Research outcomes conclude about maximum disease involvement of the mentioned age group age parity. The most repeated cause of PPH was uterine tony and we also carried out hysterectomy among patients. Keywords: Mortality, Morbidity, Maternal, Primary Postpartum Hemorrhage (PPH), Uterine Atony, Parity, Primiparous, Multiparous and Grand Multiparous.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.